Select Medical (SEM) reported Q3 adjusted earnings late Thursday of $0.50 per share, up from $0.46 a year earlier.

Analysts polled by Capital IQ expected $0.43.

Revenue for the quarter ended Sept. 30 was $1.76 billion, up from $1.67 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.74 billion.

The company said its 2024 adjusted earnings will likely be $2.09 to $2.20 per share compared with a previous guidance of $1.96 to $2.20 per share. Analysts surveyed by Capital IQ expect $2.09.

The company now expects full-year revenue of $6.95 billion to $7.15 billion from $6.9 billion to $7.1 billion, previously. Analysts polled by Capital IQ expect $7.03 billion.

Shares of Select Medical traded 5.1% higher in after-hours activity.